Assembly Biosciences, Inc. (ASMB)
25.47
+0.03
(+0.12%)
USD |
NASDAQ |
Sep 22, 16:00
25.47
0.00 (0.00%)
After-Hours: 20:00
Assembly Biosciences Market Cap : 505.59M for Sept. 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 21, 2026 | 504.99M |
| September 18, 2026 | 495.66M |
| September 17, 2026 | 503.01M |
| September 16, 2026 | 505.79M |
| September 15, 2026 | 518.29M |
| September 14, 2026 | 574.86M |
| September 11, 2026 | 591.54M |
| September 10, 2026 | 604.64M |
| September 09, 2026 | 652.48M |
| September 08, 2026 | 700.32M |
| September 04, 2026 | 726.52M |
| September 03, 2026 | 717.19M |
| September 02, 2026 | 728.90M |
| September 01, 2026 | 698.33M |
| August 31, 2026 | 667.57M |
| August 28, 2026 | 676.30M |
| August 27, 2026 | 690.79M |
| August 26, 2026 | 703.10M |
| August 25, 2026 | 701.31M |
| August 24, 2026 | 700.32M |
| August 21, 2026 | 682.45M |
| August 20, 2026 | 665.58M |
| August 19, 2026 | 671.73M |
| August 18, 2026 | 637.79M |
| August 17, 2026 | 595.71M |
| Date | Value |
|---|---|
| August 14, 2026 | 654.07M |
| August 13, 2026 | 594.52M |
| August 12, 2026 | 537.15M |
| August 11, 2026 | 541.32M |
| August 10, 2026 | 424.96M |
| August 07, 2026 | 424.01M |
| August 06, 2026 | 420.35M |
| August 05, 2026 | 421.70M |
| August 04, 2026 | 420.20M |
| August 03, 2026 | 403.03M |
| July 31, 2026 | 399.06M |
| July 30, 2026 | 414.16M |
| July 29, 2026 | 399.06M |
| July 28, 2026 | 406.37M |
| July 27, 2026 | 411.77M |
| July 24, 2026 | 406.05M |
| July 23, 2026 | 400.81M |
| July 22, 2026 | 413.84M |
| July 21, 2026 | 420.67M |
| July 20, 2026 | 398.26M |
| July 17, 2026 | 426.08M |
| July 16, 2026 | 410.66M |
| July 15, 2026 | 424.80M |
| July 14, 2026 | 425.28M |
| July 13, 2026 | 428.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 189.50B |
| BridgeBio Pharma, Inc. | 13.52B |
| ACADIA Pharmaceuticals, Inc. | 4.544B |
| Alnylam Pharmaceuticals, Inc. | 33.65B |
| Anika Therapeutics, Inc. | 279.04M |
Market Cap Related Metrics
| PS Ratio | 5.470 |
| Price to Book Value | 1.654 |
| Price | 25.47 |
| Earnings Yield | -0.29% |